IGAKU SEIBUTSUGAKU KENKYUSHO KK has a total of 11 patent applications. It increased the IP activity by 0.0%. Its first patent ever was published in 2007. It filed its patents most often in Japan. Its main competitors in its focus markets biotechnology, pharmaceuticals and measurement are BOWDISH KATHERINE S, FORERUNNER PHARMA RES CO LTD and ADURO BIOTECH HOLDINGS EUROP B V.
# | Country | Total Patents | |
---|---|---|---|
#1 | Japan | 11 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Measurement |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Analysing materials | |
#3 | Therapeutic chemical compounds | |
#4 | Medical preparations | |
#5 | Microorganisms |
# | Name | Total Patents |
---|---|---|
#1 | Kishi Yoshiro | 2 |
#2 | Taji Shingo | 2 |
#3 | Takahashi Takashi | 2 |
#4 | Ono Kenichiro | 2 |
#5 | Morino Kazuhiko | 1 |
#6 | Yamamoto Masatada | 1 |
#7 | Okamoto Naoko | 1 |
#8 | Otaka Hironori | 1 |
#9 | Takanami Minae | 1 |
#10 | Masutomi Kenkichi | 1 |
Publication | Filing date | Title |
---|---|---|
JP2019110909A | Epitope peptides of cytotoxic t lymphocyte and uses thereof | |
JP2019062870A | Marker molecule for gs discrimination | |
JP2014143982A | T cell receptor and use thereof | |
JP2014057542A | Antibody having enhanced adcc activity and method for manufacturing the same | |
JP2014139139A | Monoclonal antibody to human telomerase reverse transcriptase | |
JP2011149859A | Esophagus cancer marker | |
JP2010284135A | New gene family ecsa | |
JP2010235447A | Inhibitory agent for inflammatory cytokine |